Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-03-19

Clinical Trial Update: Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors

View source ↗

Summary

Update on the clinical application of the PET tracer 18F-FLT for imaging lung tumors, discussing its potential utility in evaluating lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 18F-FLT (fluorothymidine)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Lung Cancer | Status: UNKNOWN